ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer
November 10, 2021Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced that an Investigational New Drug application (IND) for a trial of PXS-5505 in hepatocellular carcinoma (HCC)... -
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model
August 05, 2021Clinical stage drug development company Pharmaxis Ltd today announced the first public presentation of data from a preclinical study of PXS-5505 in the liver cancer, cholangiocarcinoma (CCA) at the Americas Hepato-Pancreato-Biliary Association (AHBPA) ...
Pharma Sources Insight January 2025
